The protein alterations driven by HPV-induced oncoproteins may contribute to the significantly lower expression levels of the five proteins found in the serum at diagnosis in patients treated for p16+ HNSCC. The gene discussed is CDKN2A; the disease is head and neck squamous cell carcinoma.